跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SELEXID - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SELEXID
Authorized
STANDARD
SELEXID
KARO HEALTHCARE AB
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
5b9312ef9a66d2c7
Company
KARO HEALTHCARE AB
Type
Standard
Approval Details
Approval Id
5b9312ef9a66d2c7
Drug Approval Canada Name
SELEXID
Product Name
SELEXID
Status
Approved
Status Date
2024-02-01
Din
02456664
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
08:12.16
Atc Original
J01CA08 PIVMECILLINAM
Atc Name
j 01 ca 08
Aig Number
0158390001
Company Name
KARO HEALTHCARE AB
Company Address
Po Box 16184, Stockholm, --, Sweden, 10324
Company Detail Path
/organization/karo-healthcare-ab
Company Information
Pharmaceutical Company Name
KARO HEALTHCARE AB
Country Name
Sweden
City Name
maidenhead,country_gb
Address
C/O Karo Healthcare Uk Limited
Website
http://www.karobio.se
Active Ingredients
PIVMECILLINAM HYDROCHLORIDE
200 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
5b9312ef9a66d2c7
Type
Standard
Back to Health Canada Approvals